Brief: Palatin Technologies Announces Mutual Termination Of License Agreement With AMAG Pharmaceuticals For Vyleesi
27/07/2020 12:26
July 27 (Reuters) - Palatin Technologies Inc PTN.A :
* PALATIN TECHNOLOGIES ANNOUNCES MUTUAL TERMINATION OF
LICENSE
AGREEMENT WITH AMAG PHARMACEUTICALS FOR VYLEESI®
* PALATIN TECHNOLOGIES INC - COMPANY TO RECEIVE $16.3
MILLION FROM
AMAG
* PALATIN TECHNOLOGIES INC - PALATIN REGAINS ALL RIGHTS
Source text for Eikon: ID:nPn7RKPQ4a
Further company coverage: PTN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palatin Technologies
See all newsPalatin Technologies Inc reports results for the quarter ended March 31 - Earnings Summary
Palatin Technologies Inc expected to post a loss of $1.20 a share - Earnings Preview
Palatin Technologies Q2 revenue rises yr/yr, net loss widens
Brief: Palatin Announces 1-For-50 Reverse Stock Split
Brief: Palatin Announces Positive Preclinical Efficacy Data For Oral MC4R Agonist PL7737 In Animal Model Of Obesity